SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company

BALA CYNWYD, Pa., Dec. 15, 2014 /PRNewswire/ -- Law office of Brodsky  & Smith, LLC announces that it is investigating potential claims against the Board  of Directors of Cubist Pharmaceuticals,  Inc. ("Cubist Pharmaceuticals" or the "Company") (Nasdaq-CBST- News) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Merck & Co.

Click here to learn more about the investigation http://brodsky-smith.com/865-cbst-cubist-pharmaceuticals-inc.html, or call: 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, Cubist Pharmaceuticals shareholders will receive $102.00 in cash for each share of Cubist Pharmaceuticals common stock they own. The investigation concerns whether the Board of Cubist Pharmaceuticals breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Merck & Co. is underpaying for Cubist  Pharmaceuticals shares.

If you own shares of Cubist Pharmaceuticals common stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala  Cynwyd,  PA  19004, by e-mail  at [email protected], by visiting http://brodsky-smith.com/865-cbst-cubist-pharmaceuticals-inc.html, or calling toll  free  877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and case action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-brodsky--smith-llc-announces--investigation-of--the-board-of-directors-of-cubist-pharmaceuticals-inc-regarding-the-fairness-of-the-sale-of-the-company-300010080.html

SOURCE Brodsky & Smith, LLC

Related Links

http://www.brodsky-smith.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED